ORTHOFIX MEDICAL INC (OFIX) Stock Fundamental Analysis

NASDAQ:OFIX • US68752M1080

13.04 USD
+0.29 (+2.27%)
At close: Feb 25, 2026
13.01 USD
-0.03 (-0.23%)
After Hours: 2/25/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Taking everything into account, OFIX scores 2 out of 10 in our fundamental rating. OFIX was compared to 185 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of OFIX have multiple concerns. OFIX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year OFIX has reported negative net income.
  • OFIX had a positive operating cash flow in the past year.
  • OFIX had negative earnings in each of the past 5 years.
  • In multiple years OFIX reported negative operating cash flow during the last 5 years.
OFIX Yearly Net Income VS EBIT VS OCF VS FCFOFIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • OFIX has a Return On Assets of -14.31%. This is comparable to the rest of the industry: OFIX outperforms 56.76% of its industry peers.
  • OFIX's Return On Equity of -26.92% is in line compared to the rest of the industry. OFIX outperforms 57.84% of its industry peers.
Industry RankSector Rank
ROA -14.31%
ROE -26.92%
ROIC N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
OFIX Yearly ROA, ROE, ROICOFIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • With a decent Gross Margin value of 68.27%, OFIX is doing good in the industry, outperforming 74.59% of the companies in the same industry.
  • In the last couple of years the Gross Margin of OFIX has declined.
  • The Profit Margin and Operating Margin are not available for OFIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
OFIX Yearly Profit, Operating, Gross MarginsOFIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • OFIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OFIX Yearly Shares OutstandingOFIX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OFIX Yearly Total Debt VS Total AssetsOFIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • OFIX has an Altman-Z score of 1.15. This is a bad value and indicates that OFIX is not financially healthy and even has some risk of bankruptcy.
  • OFIX's Altman-Z score of 1.15 is in line compared to the rest of the industry. OFIX outperforms 52.43% of its industry peers.
  • A Debt/Equity ratio of 0.39 indicates that OFIX is not too dependend on debt financing.
  • OFIX's Debt to Equity ratio of 0.39 is in line compared to the rest of the industry. OFIX outperforms 47.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACC9.59%
OFIX Yearly LT Debt VS Equity VS FCFOFIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • OFIX has a Current Ratio of 2.47. This indicates that OFIX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.47, OFIX is in line with its industry, outperforming 49.19% of the companies in the same industry.
  • A Quick Ratio of 1.38 indicates that OFIX should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.38, OFIX is not doing good in the industry: 60.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 1.38
OFIX Yearly Current Assets VS Current LiabilitesOFIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The earnings per share for OFIX have decreased strongly by -8500.00% in the last year.
EPS 1Y (TTM)-8500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.36%

3.2 Future

  • The Earnings Per Share is expected to grow by 37.50% on average over the next years. This is a very strong growth
  • OFIX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.93% yearly.
EPS Next Y-175.64%
EPS Next 2Y-37.19%
EPS Next 3YN/A
EPS Next 5Y37.5%
Revenue Next Year5.93%
Revenue Next 2Y6.08%
Revenue Next 3Y5.43%
Revenue Next 5Y5.93%

3.3 Evolution

OFIX Yearly Revenue VS EstimatesOFIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
OFIX Yearly EPS VS EstimatesOFIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • OFIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OFIX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OFIX Price Earnings VS Forward Price EarningsOFIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OFIX Per share dataOFIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • A cheap valuation may be justified as OFIX's earnings are expected to decrease with -37.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.19%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OFIX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORTHOFIX MEDICAL INC

NASDAQ:OFIX (2/25/2026, 8:00:02 PM)

After market: 13.01 -0.03 (-0.23%)

13.04

+0.29 (+2.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-24
Earnings (Next)05-04
Inst Owners91.28%
Inst Owner Change-0.03%
Ins Owners1.4%
Ins Owner Change-0.65%
Market Cap516.38M
Revenue(TTM)N/A
Net Income(TTM)-119.12M
Analysts83.33
Price Target18.36 (40.8%)
Short Float %2.61%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.73%
Min EPS beat(2)-37.41%
Max EPS beat(2)9.96%
EPS beat(4)3
Avg EPS beat(4)47.99%
Min EPS beat(4)-37.41%
Max EPS beat(4)139.22%
EPS beat(8)7
Avg EPS beat(8)81.32%
EPS beat(12)11
Avg EPS beat(12)87.39%
EPS beat(16)13
Avg EPS beat(16)57.92%
Revenue beat(2)2
Avg Revenue beat(2)0.97%
Min Revenue beat(2)0.8%
Max Revenue beat(2)1.14%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.14%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)-1.67%
Revenue beat(16)5
Avg Revenue beat(16)-1.56%
PT rev (1m)-10.96%
PT rev (3m)-10.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.95%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF 17.58
P/B 1.17
P/tB 3
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-2.32
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.74
OCFY5.69%
SpS20.66
BVpS11.17
TBVpS4.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.31%
ROE -26.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.27%
FCFM N/A
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
F-Score5
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.23%
Cap/Sales 3.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 1.38
Altman-Z 1.15
F-Score5
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)86.5%
Cap/Depr(5y)81.89%
Cap/Sales(3y)6%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
EPS Next Y-175.64%
EPS Next 2Y-37.19%
EPS Next 3YN/A
EPS Next 5Y37.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%1.36%
Revenue Next Year5.93%
Revenue Next 2Y6.08%
Revenue Next 3Y5.43%
Revenue Next 5Y5.93%
EBIT growth 1Y-2.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year203.93%
EBIT Next 3Y51.06%
EBIT Next 5Y29.89%
FCF growth 1Y96.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.14%
OCF growth 3Y11.71%
OCF growth 5Y-4.22%

ORTHOFIX MEDICAL INC / OFIX FAQ

Can you provide the ChartMill fundamental rating for ORTHOFIX MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to OFIX.


What is the valuation status of ORTHOFIX MEDICAL INC (OFIX) stock?

ChartMill assigns a valuation rating of 0 / 10 to ORTHOFIX MEDICAL INC (OFIX). This can be considered as Overvalued.


Can you provide the profitability details for ORTHOFIX MEDICAL INC?

ORTHOFIX MEDICAL INC (OFIX) has a profitability rating of 2 / 10.


How financially healthy is ORTHOFIX MEDICAL INC?

The financial health rating of ORTHOFIX MEDICAL INC (OFIX) is 3 / 10.